AMAG Pharmaceuticals Inc
Most Recent
Amazon Dealt with Regulators Last Week
Amazon, Apple, Google, and Facebook have been fending off probes about corporate governance policy for managing user data.
Spectrum Pharmaceuticals: Earnings Trends and Recent Developments
In the first nine months of 2018, Spectrum Pharmaceuticals reported a net income and diluted EPS of -$70.8 million and -$0.69, respectively.
Spectrum Pharmaceuticals: Financial Overview in December
In the first nine months of 2018, Spectrum Pharmaceuticals’ (SPPI) net revenues declined ~20% YoY to $79.9 million from $99.8 million.
Makena Auto Injector Is a Key Asset for Antares Pharma in 2018
In H1 2018, Antares Pharma (ATRS) reported revenues of $6.7 million from its Makena product.
Antares Pharma Could Report Solid Revenue Growth in Fiscal 2018
In H1 2018, Antares Pharma (ATRS) reported revenues of $26.86 million, which was a year-over-year (or YoY) rise of 6%.
Analyst Ratings for AMAG Pharmaceuticals and Peers in February
Of the 12 analysts covering AMAG Pharmaceuticals, three have given the stock a “buy” or higher rating, and nine have given it a “hold.”
Label Expansion of Ferahame Bodes Well for AMAG Pharmaceuticals
AMAG’s revenues from Ferahame grew at a higher pace to $26 million in 3Q17 from $22.2 million in 3Q16.
A Look at AMAG Pharmaceuticals’ Collaborations
AMAG Pharmaceuticals’ business strategy includes the expansion of its portfolio through licensing and acquisitions of additional pharmaceutical products.
How Does Incyte’s Valuation Compare to Its Peers?
In this series, we’ll look at the performance of Incyte’s existing products and other factors that are driving the company’s revenues and valuation.
How Does Incyte’s Valuation Compare to Peers?
Incyte, a Delaware-based biopharmaceutical company, is focused on developing and commercializing oncology products to cater to unmet medical needs.
Outflows Resume for High Yield Bond Funds
Investor flows in high yield bond funds returned to negative territory last week, after having seen inflows in the previous week.
Leveraged Loan Fund Outflows Reach Highest Level Yet in 2015
According to Lipper, leveraged loan funds saw outflows for the week ended August 19, making it the fourth such successive week. The quantum of outflows was $754 million, the highest so far in 2015.